Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 10, No 4 (2014) MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
E. A. Belikov, K. V. Davtyan, O. N. Tkacheva
"... Prevention of thromboembolic complications in patients with atrial fibrillation during catheter ..."
 
Vol 9, No 3 (2013) ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: DRUG CHOICE AND DOSAGE ADJUSTMENT Abstract  similar documents
E. L. Dolgova, I. M. Sokolov, Yu. G. Shvarts
"... Data on the problem of thromboembolic complications in non-valvular atrial fibrillation ..."
 
Vol 11, No 2 (2015) ANTICOAGULANT THERAPY IN EVERYDAY CLINICAL PRACTICE: DATA OF THE RETROSPECTIVE CROSS-SECTIONAL STUDY Abstract  PDF (Eng)  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova, A. V. Jilenko, O. S. Anikina
"... in patients at high risk of thromboembolic events (TEE) and to evaluate clinical characteristics ..."
 
Vol 13, No 6 (2017) PREDICTORS OF THE RISK OF HEMORRHAGIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION RECEIVING LONGTERM THERAPY WITH DIRECT ORAL ANTICOAGULANTS Abstract  similar documents
A. А. Sokolova, A. V. Zhilenko, I. L. Tsarev,, D. A. Napalkov, V. V. Fomin
"... in patients before the start of anticoagulant therapy. Results. No thromboembolic events and major bleedings ..."
 
Vol 11, No 3 (2015) ANALYSIS OF THE INFLUENCE OF THROMBOEMBOLIC COMPLICATIONS PREVENTION WITH ORAL ANTICOAGULANTS ON BUDGET IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... Atrial fibrillation (AF) is a risk factor for thromboembolic complications, requiring ..."
 
Vol 15, No 1 (2019) Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular ..."
 
Vol 21, No 1 (2025) Practical aspects of perioperative management in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants Abstract  similar documents
E. N. Markova, T. Yu. Vedenikin, A. A. Kuzub, N. V. Kuchieva, A. R. Navasardyan, O. N. Dzhioeva
"...    The article is dedicated to the perioperative management of patients with non-valvular atrial ..."
 
Vol 17, No 6 (2021) Changes in Prescribing Antithrombotic Therapy in Patients with Atrial Fibrillation in the Multidisciplinary Hospital in Volgograd from 2012 to 2020 Abstract  similar documents
A. S. Gerasimenko, O. V. Shatalova, V. S. Gorbatenko, V. I. Petrov
"... Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... Background. For prevention of thromboembolic events in patients with non-valvular atrial ..."
 
Vol 12, No 4 (2016) Clinical significance of new oral anticoagulants in the prevention of thromboembolic complications in patients with atrial fibrillation: not all dreams come true Abstract  similar documents
Yu. A. Bunin, S. V. Miklishanskaya
"... % of the population. Non-valvular AF increases the risk of ischemic stroke in 5-7 times. More than 50 ..."
 
Vol 12, No 5 (2016) Dabigatran Etexilate in the course of Electrical Cardioversion in Patients with Non-Valvular Atrial Fibrillation Abstract  similar documents
N. A. Novikova, A. N. Volovchenko
"... stroke. The risk of thromboembolic complications increases significantly when performing for electrical ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... For prevention of thromboembolic events in patients with non-valvular atrial fibrillation (NVAF ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... stroke and systemic thromboembolic complications (TEC), bleeding in patients with non-valvular atrial ..."
 
Vol 12, No 5 (2016) Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
I. S. Daabul, A. A. Sokolova, D. A. Napalkov
"... and CKD, in addition to increase in frequency of strokes and the thromboembolic events, also the frequency ..."
 
Vol 15, No 3 (2019) Features of Thromboembolic and Hemorrhagic Complications in Planned Surgical Interventions in Patients with Atrial Fibrillation Abstract  similar documents
L. N. Uddin, A. V. Egorov, A. A. Sokolova, N. S. Morozova, D. A. Napalkov, V. V. Fomin
"... Aim. To study the frequency and characteristics of the development of thromboembolic ..."
 
Vol 17, No 2 (2021) Anticoagulant Therapy in Patients with Non-valvular Atrial Fibrillation in Real Clinical Practice: in Appropriate Dose Reductions Abstract  similar documents
V. A. Ionin, O. I. Bliznuk, E. I. Baranova, E. V. Shlyakhto
"... Цель. Изучить частоту применения прямых оральных антикоагулянтов (ПОАК) у больных с неклапанной ..."
 
Vol 14, No 3 (2018) THROMBOSIS OF LEFT ATRIAL APPENDAGE DURING THERAPY WITH DIRECT ORAL ANTICOAGULANT. CLINICAL CASE Abstract  similar documents
I. S. Daaboul, S. Yu. Koroleva, A. A. Kudrjavtseva, A. A. Sokolova, D. A. Napalkov, V. V. Fomin
"... of thromboembolic complications. In connection with the categorical refusal of the patient from warfarin ..."
 
Vol 12, No 3 (2016) THE PREDICTION OF ATRIAL FIBRILLATION RECURRENCE AT VARIOUS METHODS OF SINUS RHYTHM RECOVERY Abstract  PDF (Eng)  similar documents
T. Y. Gromyko, S. A. Sayganov
"... восстановления синусового ритма.  Материал и методы. Обследовано 153 пациента с неклапанной формой ФП ..."
 
Vol 13, No 1 (2017) CLINICAL AND ECONOMICAL COMPARISON OF RIVAROXABAN AND APIXABAN USE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
S. V. Nedogoda, I. N. Barykina, A. S. Salasiuk, V. O. Smirnova
"... and apixaban in patients with non-valvular atrial fibrillation (AF) and to assess the impact of the both ..."
 
Vol 8, No 5 (2012) RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE Abstract  similar documents
I. V. Grajfer, L. E. Kuvshinova, P. V. Dolotovskaya, O. V. Reshet'ko, N. V. Furman
"... fibrillation (AF) with the risk level of thromboembolic complications (TEC), calculated with the СHADS2 and CHA ..."
 
Vol 7, No 4 (2011) LEFT VENTRICULAR CLOT LYSIS DUE TO COMBINED ANTICOAGULANT THERAPY WITH WARFARIN AND FRAXIPARINE IN PATIENT WITH DILATED CARDIOMYOPATHY AND CHRONIC HEART FAILURE. THE CLINICAL CASE Abstract  similar documents
O. V. Uskova, K. O. Sobolev, G. E. Gendlin, A. V. Melekhov
"... failure and high risk of thromboembolic events is described.   ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... -valvular atrial fibrillation (NVAF) during preparation for elective cardioversion. Material and methods ..."
 
Vol 6, No 4 (2010) ANTITHROMBOTIC THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: PROBLEMS AND PROSPECTS Abstract  similar documents
A. Y. Rychkov, N. Y. Khor'kova, A. A. Bliznyakov
"... of clinical studies on the possibility of effective reduction in frequency of thromboembolic complications ..."
 
Vol 17, No 2 (2021) Laboratory predictors of clinical outcomes in patients with atrial fibrillation Abstract  similar documents
A. A. Sokolova, I. V. Goncharova, A. A. Vedernikov, N. S. Morozova, D. A. Napalkov
"... -dimer levels in the development and progression of AF and its thromboembolic complications according ..."
 
Vol 17, No 3 (2021) Treatment and Secondary Prevention of Venous Thromboembolism in Real Clinical Practice Based on Health Care Professional Survey Abstract  similar documents
K. V. Lobastov, A. R. Navasardyan, I. V. Schastlivtsev
"... Цель. Оценить длительность применения антикоагулянтов для лечения венозных тромбоэмболических ..."
 
Vol 8, No 3 (2012) RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
M. Yu. Gilyarov
 
Vol 10, No 2 (2014) SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT Abstract  similar documents
E. A. Drozdova
"... of the management of patients with stroke due to non-valvular atrial fibrillation and secondary stroke prevention ..."
 
Vol 9, No 2 (2013) ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES Abstract  similar documents
Z. M. Safiullina, S. V. Shalaev
"... дабигатрана, прямых ингибиторов Xа фактора свёртывания ривароксабана и апиксабана в лечении неклапанной формы ..."
 
Vol 11, No 6 (2015) Clinical and economic analysis of the use of apixaban for the treatment of venous thromboembolic events Abstract  similar documents
O. V. Shatalova
"... терапией у больных с венозными тромбоэмболическими осложнениями (ВТЭО). Материал и методы. Экономическая ..."
 
Vol 17, No 2 (2021) Treatment Strategy Options in Inoperable Chronic Thromboembolic Pulmonary Hypertension Patients Abstract  similar documents
N. V. Marukyan, M. A. Simakova, D. D. Zubarev, O. M. Moiseeva
"... and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). The authors emphasize ..."
 
Vol 14, No 5 (2018) Anticoagulant Therapy in Difficult Patients with Atrial Fibrillation: When the Risks of Embolism and Bleeding Are Comparable Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, M. A. Gabitova, L. N. Uddin
"... with atrial fibrillation: those  who have high bleeding and high thromboembolic risk and elderly. The focus ..."
 
Vol 10, No 3 (2014) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... Adequate primary and secondary prevention of thromboembolic complications is one of the main goals ..."
 
Vol 11, No 6 (2015) PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD Abstract  similar documents
L. Y. Koroleva, I. V. Kolesnichenko, V. P. Nosov, I. I. Gritsenko, E. S. Timoschenko
"... Adequate primary and secondary prevention of thromboembolic complications is one of the main goals ..."
 
Vol 18, No 6 (2022) Perioperative Management of Patients Receiving Antithrombotic Therapy in Schemes and Algorithms Abstract  similar documents
O. N. Dzhioeva, E. A. Rogozhkina, O. M. Drapkina
"... and thromboembolic complications? Perioperative management of patients who take antithrombotic drugs for a long time ..."
 
Vol 7, No 2 (2011) PATHOGENETIC MECHANISMS AND TREATMENT PRINCIPLES OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION Abstract  similar documents
N. A. Shostak, A. A. Klimenko, N. A. Demidova, I. V. Novikov
"... Data about chronic thromboembolic pulmonary hypertension (CTPH) prevalence is presented. The main ..."
 
Vol 11, No 3 (2015) PHARMACOECONOMIC ASPECTS OF THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER LARGE JOINTS REPLACEMENT Abstract  similar documents
A. V. Rudakova
"... Venous thromboembolic (VTE) events are a major concern in large joints replacement leading ..."
 
Vol 10, No 1 (2014) CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION AND PROBLEMS OF RARE AND INTERDISCIPLINARY DISEASE Abstract  similar documents
N. A. Shostak, A. A. Klimenko, N. A. Demidova
"... Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare life-threatening disease ..."
 
Vol 16, No 2 (2020) Specificities of Approaches to Anticoagulant Therapy in Comorbid Patients with Atrial Fibrillation, Diabetes Mellitus and Impaired Kidney Function Abstract  similar documents
N. V. Drobotya, E. Sh. Guseynova, A. A. Pirozhenko
"... comprehensively. Along with the prevention of thromboembolic complications, it is necessary that the selected ..."
 
Vol 12, No 4 (2016) Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation Abstract  similar documents
S. G. Kanorskii
"... in routine clinical practice in patients with non-valvular atrial fibrillation. In consecutive patients who ..."
 
Vol 10, No 2 (2014) ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Maslakov
"... . Acetylsalicylic acid was prescribed to 0.7% of cases (n=2), warfarin – to 5% (n=12). High risk of thromboembolic ..."
 
Vol 16, No 2 (2020) Soluble Guanylate Cyclase Stimulators for Chronic Thromboembolic Pulmonary Hypertension Patients Treatment: New Data Abstract  similar documents
M. A. Simakova, O. M. Moiseeva
"... pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). It has been ..."
 
Vol 10, No 3 (2014) THE FIRST EXPERIENCE OF LEFT ATRIAL APPENDAGE OCCLUDING DEVICES IMPLANTATION FOR PREVENTION OF STROKE IN THE STATE RESEARCH CENTRE FOR PREVENTIVE MEDICINE Abstract  similar documents
K. V. Davtyan, O. N. Tkacheva, A. A. Kalemberg, S. N. Koretsky
"... Some aspects of prevention of thromboembolic events in patients with atrial fibrillation ..."
 
Vol 18, No 1 (2022) Modern Anticoagulant Therapy for Atrial Fibrillation: Patient Adherence in Clinical Practice Abstract  similar documents
Yu. P. Skirdenko, N. A. Nikolaev, K. G. Pereverzeva, A. Yu. Timakova, A. S. Galus, S. S. Yakushin
"... at high risk of thromboembolic complications in Ryazan and Omsk. To study adherence, a questionnaire ..."
 
Vol 17, No 5 (2021) Gastrointestinal Bleeding: a Cardiologist's Point of View Abstract  similar documents
O. V. Averkov, L. N. Mishchenko
"... of thromboembolic events: in atrial fibrillation, deep vein thrombosis/pulmonary embolism, acute coronary syndrome ..."
 
Vol 19, No 2 (2023) Left Atrial Thrombosis before Catheter Ablation or Cardioversion in Patients with Non-valvular Atrial Fibrillation or Atrial Flutter: what Risk Score is Most Informative? Abstract  similar documents
I. A. Zaigraev, I. S. Yavelov, O. M. Drapkina, E. V. Bazaeva
"... (LAAT) in patients with non-valvular atrial fibrillation (AF) or atrial flutter (AFL) undergoing ..."
 
Vol 16, No 6 (2020) Thrombotic Lesion of the Pulmonary Vessels in Patients with Pulmonary Embolism Abstract  similar documents
A. A. Klimenko, N. A. Demidova, N. A. Shostak, M. O. Anischenko
"... of the disease, from asymptomatic residual pulmonary thrombosis to the formation of chronic thromboembolic ..."
 
Vol 16, No 4 (2020) Real-Life International Normalized Ratio Profile in Patients with Non-Valvular Atrial Fibrillation Prescribed Vitamin K Antagonist Abstract  PDF (Eng)  similar documents
S. I. Farag, O. S. Arafa, A.A. E. Hassan, H. M. Mashhour, A. M. Bendary
"... of INR/Patient. Material and methods. A total of 200 patients with non-valvular atrial fibrillation ..."
 
Vol 14, No 2 (2018) NEW DIRECT ORAL ANTICOAGULANTS FOR TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION IN REAL-WORLD SETTING Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, A. A. Shavarov
"... Large randomized clinical trials (RCTs) in patients with non-valvular atrial fibrillation (AF ..."
 
Vol 13, No 2 (2017) APPROACHES TO ANTITHROMBOTIC THERAPY IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. A. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... tools used to assess risks of thromboembolic and hemorrhagic complications and general approaches ..."
 
Vol 8, No 1 (2012) PHARMACOECONOMIC EVALUATION OF DABIGATRAN VS WARFARIN IN CARDIOVASCULAR EVENTS PREVENTION IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION Abstract  similar documents
Yu. B. Belousov, V. Yu. Mareev, I. S. Yavelov, D. Yu. Belousov
 
Vol 15, No 4 (2019) Elderly Patients with Atrial Fibrillation: Focus on Comorbidity and Safety of Anticoagulant Therapy Abstract  similar documents
D. A. Napalkov, A. A. Sokolova
"... and XANTUS-EL registers. 96% of patients in the study did not have serious thromboembolic events. The amount ..."
 
Vol 18, No 3 (2022) Risk of Venous Thromboembolic Complications in Patients with Atrial Fibrillation: a Systematic Review and Meta-analysis Abstract  PDF (Eng)  similar documents
A. A. Sokolova, A. A. Kudriavtseva, N. V. Kostokova, M. P. Zaikina, Z. A. Gebekova, D. A. Napalkov, I. A. Zolotukhin
"... тромбоэмболических осложнений (ВТЭО). Материал и методы. Поиск литературы производился в базах данных PubMed ..."
 
Vol 12, No 6 (2016) Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis Abstract  PDF (Eng)  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov
"... стандартной терапией венозных тромбоэмболических осложнений (ВТЭО). Материал и методы. Выполнен мета-анализ ..."
 
Vol 12, No 1 (2016) Efficacy and safety of the new oral anticoagulants in the treatment of venous thromboembolic complications: meta-analysis Abstract  similar documents
V. I. Petrov, O. V. Shatalova, V. S. Gorbatenko, O. N. Smuseva, A. S. Maslakov
"... стандартной терапией венозных тромбоэмболических осложнений (ВТЭО). Материал и методы. Выполнен мета-анализ ..."
 
Vol 7, No 3 (2011) REDUCTION DEGREE OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL LEVELS ACCORDING TO DIFFERENT DOSES OF STATINS; ITS EFFECT ON THE RISK OF ISCHEMIC HEART DISEASE ACUTE EPISODES DEPENDING ON TREATMENT DURATION; AND RISK OF ISCHEMIC AND THROMBOEMBOLIC STROKE. COMMENT ON THE PAPER OF LAW M.R., WALD N.J., RUDNICKA A.R. QUANTIFYING EFFECT OF STATINS ON LOW DENSITY LIPOPROTEIN CHOLESTEROL, ISCHAEMIC HEART DISEASE, AND STROKE: SYSTEMATIC REVIEW AND META-ANALYSIS. BMJ 2003; 326:1423-1427 Abstract  similar documents
N. V. Perova
"... disease, because these patients have a higher risk of thromboembolic stroke (rather than haemorrhagic ..."
 
Vol 16, No 6 (2020) The Oral Anticoagulants Administration in Elderly Patients with Geriatric Syndromes: What's New? Abstract  similar documents
N. M. Vorobyeva, O. N. Tkacheva
"... syndromes, as well as in elderly patients with venous thromboembolic complications and frailty syndrome ..."
 
Vol 13, No 2 (2017) RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY Abstract  similar documents
. Editorial
"... профилактики повторных эпизодов венозных тромбоэмболических осложнений, при этом была продемонстрирована ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... ) are highlighted. The main statements of current Russian and international guidelines about thromboembolic events ..."
 
Vol 13, No 5 (2017) WARFARIN AND ITS IMPORTANCE IN THE ERA OF NEW ORAL ANTICOAGULANTS. ISSUES OF MONITORING THE EFFECTIVENESS AND SAFETY OF TREATMENT Abstract  similar documents
S. Yu. Martsevich, Y. V. Lukina
"... in patients with non-valvular AF, therefore, in valvular AF, as well as in patients with severe renal failure ..."
 
Vol 20, No 1 (2024) Effect of CYP3A4/5, ABCB1 gene polymorphisms on the residual equilibrium concentration of apixaban and bleeding in patients with non-valvular atrial fibrillation and deep vein thrombosis Abstract  similar documents
l. V. Fedina, i. N. Sychev, K. V. Mirzaev, A. V. Vardanyan, S. V. Glagolev, A. A. Kachanova, P. O. Bochkov, R. V. Shevchenko, S. N. Tuchkova, I. V. Sychev, S. P. Abdullaev, D A. Sychev
"... apixaban. Material and methods. The study included 108 patients with non-valvular atrial fibrillation ..."
 
Vol 9, No 3 (2013) REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY Abstract  similar documents
A. A. Klimenko, N. A. Shostak, N. A. Demidova, I. V. Novikov, S. M. Sorokoletov, S. V. Madoyan
"... -proBNP) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Material and methods ..."
 
Vol 20, No 4 (2024) Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? Abstract  similar documents
N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva
"... , the experts now believe that "long-term treatment with rivaroxaban in non-valvular atrial fibrillation (AF ..."
 
Vol 15, No 4 (2019) According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention Abstract  similar documents
Company Pfizer
"... неклапанной фибрилляции предсердий и острым коронарным синдромом и/или чрескожным коронарным вмешательством ..."
 
Vol 14, No 1 (2018) THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES Abstract  similar documents
M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. Val. Yakusevich, V. Vl. Yakusevich, T. A. Gomova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, M. A. Bichurina, L. A. Matskevich, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. D. Deev, O. M. Drapkina, s. A. Boytsov
"... values, at which the risk of cardioembolic stroke and other thromboembolic complications is proven ..."
 
Vol 12, No 4 (2016) The use of oral anticoagulants in patients with atrial fibrillation: cohort study data Abstract  similar documents
O. V. Gaisenok, A. S. Leonov
"... .2%; patient’s inability to comply with the recommendations and the valvular AF, which does not allow ..."
 
Vol 17, No 2 (2021) Analysis of Anticoagulant Therapy in the Elderly Patients, in Clinical Practice of Family Medicine Centers in the Kyrgyz Republic Abstract  similar documents
S. M. Mamatov, B. Kanat kyzy, A. O. Musakeev, N. K. Kinderbaeva, T. J. Tagaev
"... Цель. Изучить ситуацию с назначением антикоагулянтной терапии у пациентов пожилого и старческого ..."
 
Vol 17, No 2 (2021) Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage Abstract  similar documents
A. S. Gerasimenko, V. S. Gorbatenko, O. V. Shatalova, V. I. Petrov
"... антикоагулянтной терапии, которое возникает у 0,3-0,7% пациентов в год. Наличие у человека фибрилляции предсердий ..."
 
Vol 17, No 4 (2021) Changes in anticoagulant prescription in a general hospital in 2008-2018 Abstract  similar documents
E. B. Kleymenova, V. A. Otdelenov, M. D. Nigmatkulova, S. A. Payushchik, A. A. Chernov, O. D. Konova, L. P. Yashina, A. M. Cherkashov, D. A. Sychev
"... предсердий (ФП) за данный период. Обоснованность назначения антикоагулянтной терапии оценивалась по шкале CHA ..."
 
Vol 10, No 4 (2014) OPTIMAL PREVENTION OF HOSPITAL VENOUS THROMBOEMBOLISM WITH THE HELP OF MEDICAL INFORMATION SYSTEM Abstract  similar documents
G. I. Nazarenko, S. A. Payushk, V. A. Otdelenov, E. B. Kleymenova, L. P. Yashina, D. A. Sychev
"... of clinical guidelines for the prevention of venous thromboembolic complications there is a gap between ..."
 
Vol 14, No 4 (2018) Possibilities of Using Rivaroxaban in Elderly Patients with Atrial Fibrillation: Data from Randomized Studies and Real Clinical Practice Abstract  similar documents
N. M. Vorobyeva, O. N. kacheva
"... The possibility of rivaroxaban using in elderly patients with non-valvular atrial fibrillation ..."
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
"... тромбоэмболических осложнений. Важнейшая роль в терапии ФП отводится антикоагулянтам, т.к именно антикоагулянтая ..."
 
Vol 20, No 4 (2024) Clinical application of clinical decision support systems in the management of patients with atrial fibrillation Abstract  similar documents
A. V. Ponomarenko, A. D. Gavrilko, A. A. Gartung, M. S. Poliakova, A. A. Oganesyan, K. S. Benimetskaya, D. V. Losik, S. V. Shalaev
"... of thromboembolic complications. This article discusses the positive and negative aspects of using CDSS ..."
 
Vol 17, No 2 (2021) Dynamics of Kidney Function in Patients with Chronic Kidney Disease and Atrial Fibrillation Who Receive Dabigatran Abstract  PDF (Eng)  similar documents
N. A. Novikova, Z. K. Salpagarova, M. I. Chashkina, A. A. Bykova, Z. A. Alimova, А. S. Yadykina, D. F. Mesitskaya, N. A. Babakova, D. A. Andreev
"... . The anticoagulant therapy should be prescribed to prevent thromboembolic events. According to randomized clinical ..."
 
Vol 15, No 4 (2019) Optimization of Pharmacotherapy with Direct Oral Anticoagulants: the Need to Choose the Right Dosage Regimen Abstract  similar documents
A. I. Kochetkov, O. D. Ostroumova
"... пациентов, нуждающихся в антикоагулянтной терапии, для оптимальной профилактики системных тромбоэмболических ..."
 
Vol 16, No 2 (2020) The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment Abstract  similar documents
К. V. Lobastov, I. V. Schastlivtsev
"... тромбоэмболических осложнений (ВТЭО) у онкологических больных. В соответствии с современными рекомендациями ..."
 
Vol 3, No 2 (2007) VARFARIN DOSE REGIME APPROACHS BASED ON PHARMACOGENETICS TEST RESULTS: REAL POSSIBILITY TO OPTIMIZE THE PHARMACOTHERAPY Abstract  similar documents
D. A. Sychev, I. M. Antonov, S. V. Zagrebin, N. A. Gasanov, V. G. Kukes
"... Indirect anticoagulants effectively prevent thromboembolic complications in patients with high ..."
 
Vol 17, No 1 (2021) Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction Abstract  similar documents
Z. D. Kobalava, A. A. Shavarov, M. V. Vatsik-Gorodetskaya
"... with increased risk of stroke and thromboembolic complications. Oral anticoagulation for stroke prevention ..."
 
Vol 18, No 5 (2022) Thrombocytopenia Induced by Direct Oral Anticoagulants: a Clinical Case and Literature Review Abstract  similar documents
B. A. Tatarsky, N. V. Kazennova
"... oral anticoagulants are used for the prevention of thromboembolic complications in patients with atrial ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... be considered in patients with low adherence for prevention of thromboembolic complications. ..."
 
Vol 18, No 6 (2022) Effect of ABCB1 Gene Carriage and Drug-Drug Interactions on Apixaban and Rivaroxaban Pharmacokinetics and Clinical Outcomes in Patients with Atrial Fibrillation and Deep Vein Thrombosis Abstract  similar documents
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, E. V. Strigunkova, A. A. Kachanova, Z. A. Sozaeva, P. O. Bochkov, A. V. Vardanyan, K. B. Mirzayev, D. A. Sychev
"... patients (50 patients received apixaban and 42 – rivaroxaban) with non-valvular atrial fibrillation ..."
 
Vol 17, No 6 (2021) Anticoagulants after Discharge in Patients with COVID-19: What we Know at the End of 2021 Abstract  similar documents
I. S. Yavelov
"... and thromboembolic complications in patients with COVID-19 after discharge from the hospital are presented. Large ..."
 
Vol 13, No 5 (2017) LEFT ATRIAL FUNCTION: MODERN ASSESSMENT METHODS AND CLINICAL SIGNIFICANCE Abstract  similar documents
E. N. Pavlyukova, D. A. Kuzhel, G. V. Matyushin
"... cardiovascular outcomes in patients with cardiomyopathy, ischemic heart disease and valvular heart disease ..."
 
Vol 14, No 4 (2018) Elderly Patient Management Problems: Antithrombotic Therapy Selection Features. Clinical Case Abstract  similar documents
D. U. Akasheva, E. S. Bulgakova, I. S. Yavelov, A. Yu. Gorshkov, O. M. Drapkina
"... there is higher prevalence of thromboembolic diseases (acute coronary syndrome, venous thromboembolism, atrial ..."
 
Vol 16, No 2 (2020) Algorithm for the Choice of Anticoagulant for Patients with Atrial Fibrillation Abstract  similar documents
Yu. P. Skirdenko, N. A. Nikolaev
"... by the attending physician. Hemorrhagic and thromboembolic complications were assessed at the next examination ..."
 
Vol 15, No 5 (2019) Prediction of the Possibility of Hemorrhagic Syndrome during Combined Antiplatelet Therapy According to the Krasnodar Region Registry Abstract  similar documents
Z. G. Tatarintseva, E. D. Kosmacheva, S. V. Kruchinova, V. A. Akinshina, A. A. Khalafyan
"... for the prevention of recurrent cardiovascular events and anticoagulant therapy for the prevention of thromboembolic ..."
 
Vol 5, No 3 (2009) SAFETY OF LONGTERM THERAPY WITH WARFARIN: POSSIBILITY OF TREATMENT RENEWING AFTER HEMORRHAGIC COMPLICATIONS Abstract  similar documents
E. S. Kropacheva
"... Обсуждается проблема безопасности антикоагулянтной терапии. С позиций доказательной медицины ..."
 
Vol 7, No 1 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
"... Association 2015 on the use of NOAC in patients with non-valvular atrial fibrillation. The paper discusses ..."
 
Vol 13, No 5 (2017) Drug interactions of non-vitamin K antagonist oral anticoagulants: inside and outside table cells Abstract  similar documents
Sergey Nikolaevich Bel'diev, Irina Vladimirovna Medvedeva, Dmitry Jur'evich Platonov
"... of the European Heart Rhythm Association on the use of NOAC in patients with non-valvular atrial fibrillation ..."
 
Vol 9, No 5 (2013) PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
E. D. Kosmacheva, S. G. Kanorskiy, A. A. Kastanayan, N. V. Haylo, D. B. Goltyapin, E. A. Lipnitskaya, M. E. Statsenko
"... of thromboembolic events prevention in patients with atrial fibrillation is presented. ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... with the risk of thromboembolic complications, and also to study the dynamics of the frequency of administration ..."
 
Vol 12, No 2 (2016) THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE Abstract  similar documents
S. V. Moiseev
"... in patients with non-valvular atrial fibrillation. They were superior to warfarin for some indicators ..."
 
Vol 15, No 4 (2019) Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
"... oral anticoagulants for the prevention of thromboembolic complications in patients with atrial ..."
 
Vol 14, No 4 (2018) Physician’s Adherence to Clinical Guidelines for in-Hospital Anticoagulant Prescribing Abstract  similar documents
A. A. Chernov, E. V. Kleymenova, D. A. Sychev, L. P. Yashina, M. D. Nigmatkulova, V. A. Otdelenov, S. A. Payushchik
"... ). Результаты. Из 50 пациентов с ФП антикоагулянтная терапия в стационаре была назначена 43 (86%) пациентам ..."
 
Vol 14, No 6 (2018) Anticoagulant Therapy in “Fragile” Elderly Patients: Current State of the Problem Abstract  PDF (Eng)  similar documents
N. M. Vorobyeva, O. N. Tkacheva
 
Vol 10, No 4 (2014) FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW Abstract  similar documents
S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva
 
Vol 16, No 1 (2020) Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) Abstract  similar documents
N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva
"... своей эффективностью нередко изменяет антикоагулянтные свойства при назначении с другими препаратами и ..."
 
Vol 19, No 3 (2023) Recurrent bleeding during standard anticoagulant therapy in comorbid patients with atrial fibrillation: a clinical case report Abstract  similar documents
A. A. Kudriavtseva, E. V. Kolpachkova, Z. A. Gebekova, T. A. Sadulaeva, A. A. Sokolova, D. A. Napalkov
 
Vol 11, No 6 (2015) The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities Abstract  similar documents
E. A. Mershina, R. P. Myasnikov, O. V. Kulikova, M. S. Kharlap, S. N. Koretskiy, O. M. Larina, V. E. Sinitsyn, S. A. Boytsov
"... as forms with the progressive course of the disease, with heart failure, angina, thromboembolic ..."
 
Vol 13, No 1 (2017) DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT Abstract  similar documents
D. А. Napalkov, A. A. Sokolova, V. V. Fomin
"... in patients with non-valvular atrial fibrillation. These results confirm good safety profile of apixaban which ..."
 
1 - 100 of 193 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)